Revenio Group Oyj

Director's Dealing • May 7, 2024

Revenio Group Corporation: Managers' Transactions – Bill Östman

Revenio Group Corporation | Stock Exchange Release | May 07, 2024 at 16:30:00 EEST

Person subject to the notification requirement Name: Bill Östman Position: Member of the Board/Deputy member Issuer: Revenio Group Oyj

LEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATION Reference number: 61948/4/4

Transaction date: 2024-05-07 Outside a trading venue Instrument type: SHARE ISIN: FI0009010912 Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details (1): Volume: 719 Unit price: 0 EUR Aggregated transactions (1): Volume: 719 Volume weighted average price: 0 EUR

For further information, please contact

CFO Robin Pulkkinen, tel. +358 50 505 9932 robin.pulkkinen@revenio.fi

Distribution

Nasdaq Helsinki FIN-FSA Key media www.reveniogroup.fi

Revenio Group in brief

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand.

In 2023, the Group's net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Bill Östman